Study of CYR-064 Versus Placebo in Patients.

Status Recruiting

Clinical Trial Summary

Randomized, double-blinded, placebo-controlled trial to determine the safety and efficacy of CYR-064.

Clinical Trial Description

The purpose of this study is to determine the safety and effectiveness of CYR-064 in a randomized, double-blinded, placebo-controlled trial to determine the safety and efficacy of CYR064. The study will take approximately 32 weeks which will include a 4-week screening period to evaluate if participants are right for the Study, followed by a 24-week Treatment Period, and a 1 week follow up after participants have completed the Study. About 150 subjects will participate in this study in about 25 research sites in the United States. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06019000
Study type	Interventional
Source	Cyrano Therapeutics, Inc.
Contact	Rick Geoffrion
Phone	9258226461
Email	Rick@cyranotherapeutics.com
Status	Recruiting
Phase	Phase 2
Start date	September 26, 2023
Completion date	January 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05445921` - Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction	Phase 1/Phase 2
Active, not recruiting	`NCT06142565` - Treatment of Postviral Olfactory Dysfunction	N/A
Completed	`NCT04853836` - Olfactory Disfunction and Co-ultraPEALut	Phase 4
Completed	`NCT05152030` - The Clinical Applicability of the 'TIB' Olfactory Test Device
Recruiting	`NCT05837637` - The Vietnamese Smell Identification Test in the Diagnosis of Parkinson's Disease
Recruiting	`NCT05384561` - Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19	N/A
Not yet recruiting	`NCT04661800` - Study of Olfactory Disorders in Patients With Cardiac Amyloidosis	N/A
Completed	`NCT04789499` - Smell in Covid-19 and Efficacy of Nasal Theophylline	Phase 2
Recruiting	`NCT05364125` - Olfactory Training on Smell Dysfunction Patients in HK	N/A
Completed	`NCT05461365` - Intranasal Insulin for COVID-19-related Smell Loss	Phase 3
Completed	`NCT04710394` - Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell	N/A
Completed	`NCT05184192` - Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction	Phase 2
Not yet recruiting	`NCT05421221` - Olfactory Training in COVID-19 Associated Loss of Smell	N/A